510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1440-2017Class II

Eclipse Hypodermic Needle

Becton Dickinson & Co / initiated 2016-12-20 / Terminated / root cause: design

Becton Dickinson & Company began a recall of Eclipse Hypodermic Needle on . FDA classified it as Class II and gives the reason as "BD is initiating a Product Advisory for the Eclipse Hypodermic Needle because of safety complaints covering disengagement and needlestick injuries". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-1440-2017
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Becton Dickinson & Co
Product
Eclipse Hypodermic Needle
Product code
FMI Needle, Hypodermic, Single Lumen
Reason for recall
BD is initiating a Product Advisory for the Eclipse Hypodermic Needle because of safety complaints covering disengagement and needlestick injuries.
Root cause tag
design
FDA root cause
Device Design
Action
BD sent a Product Advisory Notice and Business Reply Card dated December 29, 2016 via UPS Ground delivery to their affected customers.
Quantity in commerce
263 mm units
Distribution
US Nationwide
Product codes and lots
N/A

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1440-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1440-2017Class IITerminatedVoluntary: Firm initiated